Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB14388ApprovedInvestigationalVaccines
Bordetella pertussis toxoid antigen (formaldehyde inactivated) is a vaccine.
- First approval
- United States, 1992 · European Union, 2021
- Also known as
- Bordetella Pertussis Toxoid Antigen, C
- Brand names
- Hexacima
- Vaxelis
Resolves to
Compound
What you can answer from here — as of April 02, 2025
Which companies are running trials of Bordetella pertussis toxoid antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?